Clinical Trial Update: Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a meningococcal serogroup ACYWX conjugate vaccine with the MenACWY-TT conjugate vaccine; results were posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• MenACWY-TT Conjugate Vaccine (Meningococcal ACWY conjugate vaccine (tetanus toxoid conjugate))
• Meningococcal Serogroup ACYWX Conjugate Vaccine (Meningococcal ACYWX conjugate vaccine)

Snippet

Sponsor: Emory University | Conditions: Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-07